UBS analyst Kevin Caliendo raised the firm’s price target on Dentsply Sirona (XRAY) to $18 from $16 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona price target raised to $17 from $14 at Barrington
- Dentsply Sirona price target raised to $16 from $14 at Mizuho
- DENTSPLY SIRONA Maps 24-Month Turnaround After Soft 2025
- Dentsply Sirona price target raised to $15 from $12 at Evercore ISI
- Dentsply Sirona price target raised to $14 from $13 at Stifel
